Dhingra, S., and M. Sachdeva. “Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-Targeting Inhibitor”. International Journal of Basic & Clinical Pharmacology, vol. 3, no. 1, Jan. 2017, pp. 249-54, https://www.ijbcp.com/index.php/ijbcp/article/view/991.